
croc
236 posts

croc
@contingentclaim
I eat cool beans and wash them down with some awesome sauce


"I haven't seen a real new idea in trading in at least 15 years." Tom Costello (@tcoste110) ran money at Tudor, Moore Capital, and Caxton. Built one of the first NLP-driven equity systems in 2003. 20 years managing capital, never had a down year. "Comparing what a retail trader does to what a quantitative hedge fund does is like comparing driving a bus on the New Jersey Turnpike to winning a Formula One race." We cover: - His hot take: no genuinely new trading idea in 15 years — only better people doing the same things faster - Why everyone in quant finance is a genius — and why that makes you ordinary, not special - Crypto is "super smart guys cosplaying at finance" — built for retail, which is exactly why it's the easiest money in finance right now - Why AGI won't beat the hedge fund industry — all the readily-capturable alpha is already captured - The status trap: why the path that made Paul Tudor Jones a billionaire won't work for the kid trying to copy it in 2026 - His friend the investment banker who'd quit it all to run a 10-employee ambulance supply company worth $150M - Why excitement is "wildly overbid" in finance — and why wanting an exciting trading job is itself a disqualifier - The most honest end of the financial industry — and why the media has it exactly backwards Thanks so much to Tom for coming on Odds on Open! Highlights: 00:00 Intro 01:18 Building institutional credibility for early-stage managers 03:01 The Pareto distribution of hedge fund returns 04:25 Applying the Unified Field Theory of Finance to fair value 08:14 Trading against human incentives in a deterministic market 13:54 Why allocators don’t steal alpha from prospective PMs 25:16 Evaluating career edge in quantitative finance for 2026 30:48 Paul Tudor Jones and the art of game selection 33:42 Analyzing the economic viability of starting a new fund 35:16 Identifying common retail pitfalls: Mean reversion and arbitrage 38:55 Why there hasn't been a new trading idea in 15 years 50:33 Managing tail risk: Physics vs. deterministic financial distributions 59:10 Career pathing for PMs after a fund blow-up 1:07:53 SBF and FTX: Credibility vs. the "Founder-Genius" archetype 1:13:44 Establishing proof-of-concept through audited multi-year returns






BoE: 5-4 vote split for hold >> that’s a dovish surprise *BOE: DHINGRA, TAYLOR, RAMSDEN, BREEDEN WANTED CUT TO 3.5% {gb} Mann "New analysis and current developments have moved the appropriate time for a cut in Bank Rate closer"


FED'S MIRAN: I WANT TO SHRINK THE BALANCE SHEET BY A LOT MORE, SMALLER BALANCE SHEET IS RIGHT WAY FED'S MIRAN: REGULTIONS A BIG ISSUE FOR SIZE OF FED BALANCE SHEET



🇪🇸 A research team led by Spanish oncologist Mariano Barbacid has successfully eradicated pancreatic cancer in mice for the first time, offering hope for a human cure. The experiment involved treating the mice by combining three low-toxicity drugs, according to a study published today. Dr. Barbacid has made a number of high profile discoveries in medical science, with his National Cancer Research Centre in Spain becoming one of the world's leading centres of cancer research. Pancreatic cancer is one of the most aggressive cancers, with the variant treated having a five-year survival rate of less than 5%. Clinical trials will begin soon, followed by approval for use of this treatment in humans. Follow: @europa
























